Shares of abrdn Healthcare Investors (NYSE:HQH - Get Free Report) passed below its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $19.09 and traded as low as $17.85. abrdn Healthcare Investors shares last traded at $17.9050, with a volume of 98,072 shares.
abrdn Healthcare Investors Price Performance
The firm's fifty day moving average price is $19.09 and its 200-day moving average price is $18.67.
abrdn Healthcare Investors Increases Dividend
The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 31st. Investors of record on Friday, February 20th will be given a $0.63 dividend. This represents a $2.52 dividend on an annualized basis and a yield of 14.1%. This is a boost from abrdn Healthcare Investors's previous quarterly dividend of $0.57. The ex-dividend date of this dividend is Friday, February 20th.
Hedge Funds Weigh In On abrdn Healthcare Investors
Several hedge funds have recently made changes to their positions in HQH. Royal Bank of Canada lifted its holdings in shares of abrdn Healthcare Investors by 22.0% in the 1st quarter. Royal Bank of Canada now owns 529,826 shares of the financial services provider's stock valued at $8,604,000 after purchasing an additional 95,441 shares during the last quarter. Integrated Wealth Concepts LLC purchased a new position in abrdn Healthcare Investors during the 1st quarter worth approximately $166,000. NewEdge Advisors LLC grew its stake in abrdn Healthcare Investors by 3.0% during the 1st quarter. NewEdge Advisors LLC now owns 43,233 shares of the financial services provider's stock worth $702,000 after buying an additional 1,274 shares during the last quarter. Goldman Sachs Group Inc. increased its position in abrdn Healthcare Investors by 7.2% during the first quarter. Goldman Sachs Group Inc. now owns 11,732 shares of the financial services provider's stock worth $191,000 after buying an additional 788 shares during the period. Finally, Envestnet Asset Management Inc. lifted its stake in abrdn Healthcare Investors by 9.3% in the second quarter. Envestnet Asset Management Inc. now owns 28,687 shares of the financial services provider's stock valued at $444,000 after buying an additional 2,438 shares during the last quarter. Hedge funds and other institutional investors own 32.60% of the company's stock.
About abrdn Healthcare Investors
(
Get Free Report)
abrdn Healthcare Investors NYSE: HQH is a closed-end management investment company that seeks long-term capital appreciation and current income by investing primarily in equity securities of companies operating in the healthcare sector. The fund’s portfolio generally comprises a diversified mix of domestic and international healthcare issuers, spanning pharmaceuticals, biotechnology, medical devices, healthcare services, and related industries.
The fund employs a fundamental, research-driven approach to select investments, focusing on companies with strong balance sheets, innovative product pipelines and the potential for sustainable revenue growth.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider abrdn Healthcare Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and abrdn Healthcare Investors wasn't on the list.
While abrdn Healthcare Investors currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead.
This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.